» Articles » PMID: 27402494

Glial and Neuroimmune Mechanisms As Critical Modulators of Drug Use and Abuse

Overview
Date 2016 Jul 13
PMID 27402494
Citations 142
Authors
Affiliations
Soon will be listed here.
Abstract

Drugs of abuse cause persistent alterations in synaptic plasticity that may underlie addiction behaviors. Evidence suggests glial cells have an essential and underappreciated role in the development and maintenance of drug abuse by influencing neuronal and synaptic functions in multifaceted ways. Microglia and astrocytes perform critical functions in synapse formation and refinement in the developing brain, and there is growing evidence that disruptions in glial function may be implicated in numerous neurological disorders throughout the lifespan. Linking evidence of function in health and under pathological conditions, this review will outline the glial and neuroimmune mechanisms that may contribute to drug-abuse liability, exploring evidence from opioids, alcohol, and psychostimulants. Drugs of abuse can activate microglia and astrocytes through signaling at innate immune receptors, which in turn influence neuronal function not only through secretion of soluble factors (eg, cytokines and chemokines) but also potentially through direct remodeling of the synapses. In sum, this review will argue that neural-glial interactions represent an important avenue for advancing our understanding of substance abuse disorders.

Citing Articles

Recent advances in nanotherapeutics for HIV-associated neurocognitive disorders and substance use disorders.

Lomas C, Dubey R, Perez-Alvarez G, Lopez Hernandez Y, Atmar A, Arias A Nanomedicine (Lond). 2025; 20(6):603-619.

PMID: 39963928 PMC: 11902879. DOI: 10.1080/17435889.2025.2461984.


The Rise of Fentanyl: Molecular Aspects and Forensic Investigations.

Barletta C, Di Natale V, Esposito M, Chisari M, Cocimano G, Di Mauro L Int J Mol Sci. 2025; 26(2).

PMID: 39859160 PMC: 11765396. DOI: 10.3390/ijms26020444.


Competitive Antagonism of Xylazine on α7 Nicotinic Acetylcholine Receptors and Reversal by Curcuminoids.

Chen Q, Xu Y, Tang P ACS Chem Neurosci. 2024; 16(2):232-240.

PMID: 39720886 PMC: 11741004. DOI: 10.1021/acschemneuro.4c00784.


Peptide discovery across the spectrum of neuroinflammation; microglia and astrocyte phenotypical targeting, mediation, and mechanistic understanding.

Benita B, Koss K Front Mol Neurosci. 2024; 17:1443985.

PMID: 39634607 PMC: 11616451. DOI: 10.3389/fnmol.2024.1443985.


Identifying methamphetamine use predictors in HIV infection: Immune-dopaminergic signatures in peripheral leukocytes and the role of COMT genotype.

Basova L, Riley T, Franklin D, Delorme-Walker V, Lim W, Grant I Brain Behav Immun Health. 2024; 42:100873.

PMID: 39430881 PMC: 11490913. DOI: 10.1016/j.bbih.2024.100873.


References
1.
Sekine Y, Ouchi Y, Sugihara G, Takei N, Yoshikawa E, Nakamura K . Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci. 2008; 28(22):5756-61. PMC: 2491906. DOI: 10.1523/JNEUROSCI.1179-08.2008. View

2.
Takayama N, Ueda H . Morphine-induced chemotaxis and brain-derived neurotrophic factor expression in microglia. J Neurosci. 2005; 25(2):430-5. PMC: 6725491. DOI: 10.1523/JNEUROSCI.3170-04.2005. View

3.
Roberto M, Cruz M, Gilpin N, Sabino V, Schweitzer P, Bajo M . Corticotropin releasing factor-induced amygdala gamma-aminobutyric Acid release plays a key role in alcohol dependence. Biol Psychiatry. 2010; 67(9):831-9. PMC: 2883449. DOI: 10.1016/j.biopsych.2009.11.007. View

4.
Miller A, Raison C . The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2015; 16(1):22-34. PMC: 5542678. DOI: 10.1038/nri.2015.5. View

5.
Heneka M, Carson M, El Khoury J, Landreth G, Brosseron F, Feinstein D . Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015; 14(4):388-405. PMC: 5909703. DOI: 10.1016/S1474-4422(15)70016-5. View